Posts

Very important information for Whistleblowers, Actual Empaths, Safeguarders, The Awake and anyone else taking on the vile; just report or record your information about these people, tell everyone directly in their path then get the hell away from these often above the law non-human entities for your own good!

Image
  R.I.P. Mike 🥀 Although I only spent one day last year with Mike (from down south) I got to know him quite well. From greeting him and helping him find a parking space to talking about the world as it is rather than how most people want it to appear, he was a true genuine person that appears to have taken his own life. Unfortunately his last attendance was with 2 x people who have proven themselves to be vile narcissist wannbe victim vileophiles, 1 x bully (and two people who laugh along with him), 1 x person who told me at a meal he doesn't believe anything on my blogs (even the verified evidence), 1 x man who loses the plot when you tell him something that's proven but not been on the bbc and several people who are particularly grumpy and full of themselves!! So not the type of people anybody with anything about them would want to be around! So for the leader of that event ( & this one ) to then tell me when asked about him "Well some people don't have the will...

He coined the term “entactogen” (later sometimes called “empathogen”) in the mid-1980s to describe the distinct pharmacological class of MDMA-like substances that produce emotional openness and empathy rather than classical hallucinations.

  Explore David Nichols' research Thought for 7s David E. Nichols (born 1944) is an American medicinal chemist and pharmacologist widely regarded as one of the world’s leading experts on the chemistry and pharmacology of psychedelic and related compounds. He spent most of his career at Purdue University (Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology) and is a co-founder and long-time leader of the Heffter Research Institute. Main research focus Nichols has worked for more than five decades on the structure–activity relationships (SAR) of compounds that act on the central nervous system, with particular emphasis on: Classical psychedelics (LSD and other lysergamides, psilocybin/psilocin, DMT, mescaline and its analogues) The serotonin 5-HT₂A receptor (the primary target of classical psychedelics) MDMA and related compounds Dopamine receptor ligands (including work relevant to Parkinson’s disease) He coined the term “entactogen” (later sometimes called “e...

THE FLAT ROOM

  Written by Grok Based on a treatment developed in conversation  FADE IN: EXT. VELORIA CITY CENTRE – NIGHT (PRESENT DAY) Rain falls on wet slate and sodium light. ELIAS VOSS (mid-40s, quiet face, careful eyes) stands in the exact middle of the old town. He turns slowly in a full circle, naming streets under his breath. ELIAS (soft) Harrow Lane… the cut through to Mercer… the loading alley behind the old post office… He stops. Something is missing. He has done this for years. CUT TO BLACK. TITLE: THE FLAT ROOM EXT. VELORIA SIDE STREET – NIGHT (1995) Rain again, younger. ELIAS (22) and MARCUS HALE (22, warmer, looser) walk arm-in-arm, slightly drunk, laughing. They know every door in this city. MARCUS We’ve passed this street a hundred times. ELIAS There’s nothing down here. They stop. A narrow black door, no sign, bass leaking out like a held breath. Marcus grins, pushes it open. INT. THE CLUB – CONTINUOUS A small basement. Sticky floor. Maybe thirty people. One long table aga...